Medical Writer Job Description

A medical writer converts clinical and scientific evidence into documents that a specific reader has to act on: an FDA reviewer deciding on an application, an institutional review board judging a protocol, a journal editor weighing a manuscript, or a physician choosing between therapies. The role sits in pharmaceutical and biotech sponsors, contract research organizations (CROs), medical communications agencies, device manufacturers and academic medical centers, and it divides into a handful of distinct tracks.

Regulatory writing covers the documents a health authority reviews. Writers draft clinical study protocols and amendments, investigator's brochures, clinical study reports (CSRs), and the clinical overviews and summaries that make up part of a Common Technical Document. For an investigational new drug (IND) application, a new drug application (NDA) or a biologics license application (BLA), the writer gathers results from the statistical analysis plan, the tables, listings and figures, the safety narratives and the study conduct records, then shapes them into prose that agrees with the data line for line. A CSR is a team product. Biostatisticians own the numbers, clinicians own the interpretation, regulatory affairs owns the strategy, and the writer owns the document, the timeline and the resolution of every reviewer comment.

Publications writing covers journal manuscripts, congress abstracts, posters and slide decks built from trial results. Here the writer works for named authors, usually the trial investigators, and follows journal instructions, ICMJE authorship criteria and Good Publication Practice guidance, with medical writing support disclosed in the acknowledgments. Medical affairs and education writing produces advisory board materials, training modules for field medical teams, continuing medical education content and scientific platforms. A smaller group handles patient-facing documents: informed consent forms, plain-language summaries of trial results and disease education.

The daily rhythm is less about blank-page composition than about control. A writer on a CSR might spend a morning checking that every p-value and confidence interval in the efficacy section matches its source table, the afternoon chairing a comment adjudication meeting, and the evening repairing cross-references inside a document management system such as Veeva Vault. Templates, style guides and quality-control checklists govern formatting, abbreviations and terminology, and version history is tracked because anything that reaches a regulator must be traceable back to its source.

Freelance and contract writers work across all of these tracks, often for several CROs or agencies at once. Senior writers can move into lead roles on submission teams, where the job becomes planning: mapping which documents an application needs, sequencing when each is written, and keeping key messages consistent from the first protocol through the final study report and into labeling discussions.

The typical route into medical writing runs through science rather than journalism. A life sciences degree is the usual starting point, and a doctorate (PhD, PharmD or MD) or a master's in pharmacology, biology, epidemiology or a related discipline is a common foundation. The graduate degree matters less as a line on a resume than as evidence that the candidate can read a statistical analysis plan, question an odd efficacy result and hold a credible conversation with a principal investigator. Writers with a bachelor's degree typically build in through adjacent jobs such as clinical research coordinator, regulatory associate, medical editor or quality-control reviewer at a CRO.

As a rough guide, associate writer roles suit someone with 0 to 2 years of professional writing experience, while senior regulatory roles typically follow 5 or more years of hands-on work on submission documents. A portfolio matters. Early-career applicants can use a dissertation chapter, a first-author paper, a mock CSR synopsis or a plain-language summary to show clarity and accuracy.

Knowledge to build:

• Regulatory structure: ICH guidelines on good clinical practice and clinical study reports, the Common Technical Document layout, and FDA guidance for the document types in scope
• Data literacy: tables, listings and figures; confidence intervals, hazard ratios and odds ratios; intent-to-treat versus per-protocol populations; outputs built on CDISC standards
• Literature work: PubMed and Embase searching, critical appraisal, and reference management in EndNote or Zotero
• Document control: Word templates built on styles, tracked changes, Veeva Vault or a comparable document management system, and handoffs to eCTD publishing
• Publication standards: ICMJE authorship criteria, CONSORT reporting for randomized trials, and Good Publication Practice

Voluntary credentials:

• Medical Writer Certified (MWC), developed by the Medical Writing Certification Commission in collaboration with AMWA
• Editor in the Life Sciences (ELS), awarded by the Board of Editors in the Life Sciences
• Certified Medical Publication Professional (CMPP), awarded by the International Society for Medical Publication Professionals
• Regulatory Affairs Certification (RAC), awarded by the Regulatory Affairs Professionals Society

None of these is a license to practice. ELS centers on editing, CMPP suits publications specialists, and RAC fits writers who want to move toward regulatory strategy, while the MWC covers medical writing broadly.

Working habits that separate strong writers: patience with long review cycles, the discipline to verify every number against its source instead of trusting a previous draft, and the diplomacy to tell a senior physician that the data do not support the sentence they want. Therapeutic-area depth, in oncology, rare disease or vaccines for example, is also worth building early, since knowing the endpoints and conventions of a field shortens every draft.

Because federal statistics fold medical writers into technical writers, the national numbers describe the broader occupation rather than this specialty alone. BLS counted 45,500 technical writers in its May 2025 wage survey. Its Occupational Outlook Handbook projects employment of technical writers to grow 1 percent from 2025 to 2035, slower than the average for all occupations, with about 3,200 openings projected each year, most of them expected to result from the need to replace workers who transfer to different occupations or exit the labor force. BLS names the continuing expansion of scientific and technical products as a driver of demand, and it also says growth may be slowed by artificial intelligence tools that allow these writers to be more productive.

Where the work sits matters. BLS reports that professional, scientific, and technical services employed 39% of technical writers. For medical writers, the practical split is between two employer types: sponsors that keep writing in house, and service firms such as CROs and agencies that sell writing as part of a clinical or communications contract. Each teaches different skills, and time at both builds a more flexible resume.

Regulatory change also shapes the work. FDA issued ICH E6(R3) Good Clinical Practice as final guidance in September 2025, which means writers drafting protocols, investigator materials and study plans should be working from the revised guideline and updating templates that still cite the older version. A writer who can explain what a guidance change means for a specific document, and who fixes a template before a reviewer flags it, is worth a great deal to a submission lead.

The ladder at a sponsor or large CRO usually runs from associate medical writer to medical writer, senior writer, principal or lead writer, and then into management as a group lead, associate director or director of medical writing. An alternative path stays technical: principal writers who lead the clinical sections of major submissions without managing staff. Publications writers can move toward publication planning or medical affairs strategy, and some regulatory writers cross into regulatory affairs itself.

Freelancing can be a long-term path as well as a bridge between staff roles. Contract writers who build a therapeutic-area niche and a reputation for clean first drafts can pick projects across sponsors, CROs and agencies, though they carry their own business overhead and income swings.

What protects a career here is judgment. AI tools can draft boilerplate, summarize tables and check consistency, but someone still has to decide which result belongs in the key message, reconcile a safety signal with the efficacy story, and stand behind every sentence a regulator reads. Writers who add data interpretation, submission strategy and quality oversight to their drafting speed keep the parts of the job that depend on judgment as AI tools enter document production.

Dear Hiring Manager,

I am applying for the Medical Writer position on your clinical documentation team. I finished my PhD in pharmacology last spring, and for the past eight months I have worked as a contract quality-control reviewer for a mid-sized CRO, checking clinical study reports and patient narratives against source tables before they go to sponsors.

That quality-control work taught me what separates a usable draft from a problem. I have caught efficacy tables that disagreed with the text, narratives that listed the wrong onset date for an adverse event, and abbreviations defined three different ways in one report. I now write with the reviewer in mind: every number traced, every claim tied to an output, every cross-reference live.

My doctoral research on kinase inhibitor resistance gave me the scientific grounding for oncology work. I wrote two first-author manuscripts, handled responses to peer reviewers, and drafted the methods and statistics sections alongside our department's biostatistician. I am comfortable reading a statistical analysis plan, questioning a subgroup result, and explaining a hazard ratio to a non-specialist.

I have also completed coursework toward the Medical Writer Certified credential and have been building templates in Word with styles and automated cross-references, since I know how much time broken formatting costs a submission team.

I would welcome the chance to start on protocols, narratives or CSR sections under a senior writer and grow toward leading documents on my own. Thank you for considering my application. I would be glad to share writing samples and discuss how I can support your team.

Sincerely, Jordan Ellis